Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Daytime Severe Cold & Flu is an over-the-counter (OTC) combination oral suspension developed by Genexa for the temporary relief of symptoms associated with the common cold and flu, including minor aches, pains, headache, sore throat, fever, and cough. It is formulated as a 'clean medicine' without artificial fillers, dyes, or preservatives. The product contains two active ingredients: acetaminophen, which acts as an analgesic and antipyretic, and dextromethorphan hydrobromide, which acts as an antitussive (cough suppressant).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acetaminophen + dextromethorphan.